BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9712217)

  • 21. Initial experience with clozapine in Woodbridge Hospital.
    Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
    Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine.
    Wu G; Dias P; Chun W; Li G; Kumar S; Singh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1395-400. PubMed ID: 11125862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
    Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
    J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation.
    Mendhekar DN
    J Neuropsychiatry Clin Neurosci; 2007; 19(2):196-7. PubMed ID: 17431071
    [No Abstract]   [Full Text] [Related]  

  • 25. Pregnancy and atypical antipsychotics.
    Ruzić K; Dadić-Hero E; Knez R; Medved P; Petrić D
    Psychiatr Danub; 2009 Sep; 21(3):368-70. PubMed ID: 19794358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine use in HIV-infected schizophrenia patients: a case-based discussion and review.
    Nejad SH; Gandhi RT; Freudenreich O
    Psychosomatics; 2009; 50(6):626-32. PubMed ID: 19996235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clozapine and treatment of negative symptoms].
    Lançon C; Farisse J; Llorca PM
    Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine as a first treatment for schizophrenia.
    Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
    Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clozapine for resistant schizophrenia and characteristics of those responding].
    Talmon Y; Guy N; Wittenberg N
    Harefuah; 1995 Dec; 129(11):451-4, 536. PubMed ID: 8846949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clozapine-responsive cluster headache.
    Datta SS; Kumar S
    Neurol India; 2006 Jun; 54(2):200-1. PubMed ID: 16804270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between clozapine response and allelic variation in the 5-HT2C receptor gene.
    Sodhi MS; Arranz MJ; Curtis D; Ball DM; Sham P; Roberts GW; Price J; Collier DA; Kerwin RW
    Neuroreport; 1995 Dec; 7(1):169-72. PubMed ID: 8742444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Aripiprazole in treatment resistant schizophrenia.
    Hughes D; Morcos M
    J Psychopharmacol; 2008 Nov; 22(8):927-8. PubMed ID: 18308805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine-withdrawal catatonia.
    Wadekar M; Syed S
    Psychosomatics; 2010; 51(4):355-355.e2. PubMed ID: 20587767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.
    Doruk A; Uzun O; Ozşahin A
    Int Clin Psychopharmacol; 2008 Jul; 23(4):223-7. PubMed ID: 18545061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
    Dursun SM; Szemis A; Andrews H; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
    Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
    Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.